How big is the U.S. Tremfya market?

The U.S. Tremfya market size was estimated at USD 3.00 billion in 2024 and is expected to reach USD 3.23 billion in 2025.

What is the U.S. Tremfya market growth?

The U.S. Tremfya market is projected to grow at a CAGR of 5.32% from 2025 to 2033 to reach USD 4.89 billion by 2033.

Which segment accounted for the largest U.S. Tremfya market share?

Based on application, plaque psoriasis segment dominated the market with the largest revenue share of 87.3% in 2024, driven by the increasing prevalence of moderate-to-severe cases and growing demand for targeted biologic therapies.

Who are the key players in the U.S. Tremfya market?

Johnson & Johnson Services, Inc. leads the U.S. Tremfya market, supported by its regulatory approvals, distribution systems, and pricing models. The competitive landscape includes companies such as Arven Pharmaceuticals, Biocon, and MorphoSys, which are entering the market through clinical pipelines and manufacturing capabilities. These companies aim to introduce alternative formulations and address treatment gaps. Market dynamics are influenced by pricing strategies, supply chain operations, and product availability. Competition is expected to increase due to rising demand for cost-effective and accessible therapies.

What are the factors driving the U.S. Tremfya market?

The U.S. Tremfya market is driven by expanded regulatory approvals, increasing diagnosis of immune-mediated conditions, and broader biologic adoption. Additional factors include insurance coverage, structured patient access programs, and specialty pharmacy networks. Rising healthcare spending and focus on long-term treatment adherence also support market growth. These factors collectively contribute to sustained demand for Tremfya across approved therapeutic indications.

U.S. Tremfya Market Size, Share & Trends Report

U.S. Tremfya Market (2025 - 2033) Size, Share & Trends Analysis Report By Application (Moderate-to-Severe Plaque Psoriasis, Psoriatic Arthritis (PsA)), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), And Segment Forecasts

Market Segmentation

U.S. Tremfya Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Plaque Psoriasis
- Psoriatic Arthritis (PsA)
- Others
U.S. Tremfya Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments